Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

atment. PEGASYS is also contraindicated in hepatic decompensation with Child-Pugh score greater than or equal to 6 in cirrhotic CHC patients coinfected with HIV before or during treatment. PEGASYS is also contraindicated in neonates and infants because it contains benzyl alcohol. Benzyl alcohol is associated with an increased incidence of neurological and other complications in neonates and infants, which are sometimes fatal. PEGASYS and COPEGUS therapy is additionally contraindicated in patients with a hypersensitivity to COPEGUS or any of its components, in women who are pregnant, men whose female partners are pregnant, and patients with hemoglobinopathies (eg, thalassemia major, sickle-cell anemia).

COPEGUS THERAPY SHOULD NOT BE STARTED UNLESS A REPORT OF A NEGATIVE PREGNANCY TEST HAS BEEN OBTAINED IMMEDIATELY PRIOR TO INITIATION OF THERAPY. Women of childbearing potential and men must use two forms of effective contraception during treatment and during the 6 months after treatment has concluded. Routine monthly pregnancy tests must be performed during this time. If pregnancy should occur during treatment or during 6 months post-therapy, the patient must be advised of the significant teratogenic risk of COPEGUS therapy to the fetus. Healthcare providers and patients are strongly encouraged to immediately report any pregnancy in a patient or partner of a patient during treatment or during 6 months after treatment cessation to the Ribavirin Pregnancy Registry at 1-800-593-2214.

Chronic hepatitis C (CHC) patients with cirrhosis may be at risk of hepatic decompensation and death when treated with alpha interferons, including PEGASYS. During treatment, patients' clinical status and hepatic function should be closely monitored, and PEGASYS treatment should be immediately discontinued if decompensation (Child-Pugh score greater than or equal to 6) is observed.

The most common adverse events reported for PEGASYS and COPEGUS combination therapy observed
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Levi & Korsinsky is investigating the Board of ... BIIB) for possible violations of federal securities laws. The ... and/or directors have violated Sections 10(b) and 20(a) of ... 24, 2015, prior to the opening of the market, ... other things, the Company lowered its prior revenue guidance ...
(Date:8/4/2015)... -- The Pittsburgh Life Sciences Greenhouse (PLSG), the region,s only ... of its portfolio companies, Medrobotics Corporation, has received FDA ... System in the U.S.  "I couldn,t ... John W. Manzetti , president and CEO of ... spinning out of The Robotics Institute at Carnegie Mellon ...
(Date:8/4/2015)... Aug. 4, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August ... Parker Meridien in New York . ... www.meipharma.com . A replay will be available approximately one ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2
... NEW YORK, Feb. 16, 2012 Delcath Systems, Inc. (NASDAQ: ... entered into an initial launch and training agreement for the ... Center Schleswig-Holstein (Kiel Campus), one of the largest European centers ... to commercially utilize the CHEMOSAT system to treat patients. Under ...
... Inc., a leading provider of revenue and payment ... announced a clinical services agreement with Informatics Corporation ... and results as well as EHR capabilities. ... developed by Vanderbilt Medical Center in Nashville, Tennessee, ...
Cached Medicine Technology:Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 2Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 3Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System 4Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 2Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 3Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 4Emdeon Announces Clinical Services Agreement with ICA, Educational Sessions During HIMSS12 5
(Date:8/5/2015)... , ... August 05, 2015 , ... HealthyYOU Vending says ... campaign by the City & County of San Francisco are representative of initiatives ... M. Lee recently approved a measure from the City and County of San Francisco ...
(Date:8/5/2015)... ... August 05, 2015 , ... The President ... honored as one of this year’s 50 Most Influential Women in Arizona by ... business. Carol May’s long-standing dedication to the well-being of consumers through Wisdom Natural ...
(Date:8/4/2015)... ... August 05, 2015 , ... ... Stevens as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting more than ...
(Date:8/4/2015)... ... August 05, 2015 , ... The Journal of Pain Research has ... corresponding author Professor Akiko Okifuji says “Both obesity and chronic pain are serious public ... say that one causes the other. Rather, there appear to be multiple factors that ...
(Date:8/4/2015)... ... August 04, 2015 , ... assistPoint Partners, LLC ... consolidate oncology patient assistance programs. Through a secure web portal, assistPoint connects Life ... an enterprise level, cloud-based application and workflow solution. This provides cancer center patient ...
Breaking Medicine News(10 mins):Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 2Health News:HealthyYOU Vending says San Francisco’s ‘Soda Free Summer’ Initiative and Other Recent Health-related Ordinances Demonstrate Why Healthy Vending is a Growing Industry 3Health News:Carol May Named One of the Most Influential Woman in Arizona 2Health News:Carol May Named One of the Most Influential Woman in Arizona 3Health News:Carol May Named One of the Most Influential Woman in Arizona 4Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:assistPoint.com Web Site Launched 2
... puzzling over the case of 44-year-old civil servant who has ... tiny brain . ,In a case history published ... the Hopital de la Timone in Marseille say the father-of-two ... left leg. ,Scans by computed tomography (CT) and ...
... an issue for every country and ultimately, for every food ... incidents that occurred in the last 12 months, two agencies ... when dealing with traders and producers that affect the supply ... Organization (FAO) and the World Health Organization (WHO) cited the ...
... star this week for allegedly organizing illegal dog fights has ... attracting an increasingly wide following. ,The blood ... illegal in all 50 states, but can be found across ... very prevalent in the South now it's all over, in ...
... the University Clinic of the University of Navarra have ... adult stem cell growth for its capacity to ... ,Ana Fernandez Hortelano, ophthalmologist at the hospital, applied ... cornea in 70 rabbits for the purpose of regaining ...
... containing HIV but must remove the stigma associated with the ... control, international research chiefs say. ,Speaking ahead ... next week, America's top expert Anthony Fauci and his Australian ... risk in Asia. ,Fauci said predictions HIV would ...
... drug proven effective in preventing prostate cancer, just because it ... now put their fears to rest, thanks to a new ... Oncology Group, found that though the drug does cause a ... of time. ,As a part of their study, ...
Cached Medicine News:Health News:Gaps In Food Safety Systems Must Be Plugged :UN 2Health News:Dog Fighting in the US: Bloody, Illegal and Booming 2Health News:Asia Must Overcome HIV Stigma, Say Research Chiefs 2Health News:Asia Must Overcome HIV Stigma, Say Research Chiefs 3Health News:Mens Sexual Prowess Not Affected by Prostate Cancer Drug 2
The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...
... StelKast's Proven™ knee system ... solution based on a clinically ... posterior stabilized and anatomically correct ... instrument standardization and ease of ...
... Oxinium (oxidized zirconium) isn't a new implant. ... Smith & Nephew. Wear debris can be ... almost nil, addressing the needs of the ... are all improved. Initially, Oxinium is available ...
The RT-PLUS Solution is an axially supported rotation knee prosthesis for cemented implantation. The implant is available in three sizes, each of which can be combined with the next size up or down....
Medicine Products: